Chidamide Plus Chemotherapy in the Treatment of Peripheral T-cell Lymphoma
Status:
Unknown status
Trial end date:
2019-11-01
Target enrollment:
Participant gender:
Summary
This is a single arm, prospective trial to evaluate the efficacy and safety of Chidamide in
combination with previous chemotherapy in peripheral T cell lymphoma patients who did not
achieve complete response after 3 cycles of chemotherapy in interim evaluation.